cd38 inhibitor and 5-amino-1mq synergy nad+ is a key mediator of depletion in the brain of ZIKV-infected mice: iScience The Pharmacology of CD38/NADase: An
The Pharmacology of CD38 NADase: An emerging target for cancer and aging diseases PMC CD38 Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+ Lowering Agents SLC25A51 decouples the mitochondrial NAD+ NADH ratio to control proliferation of AML cells: Cell Metabolism Emerging chemical strategies for CD38 inhibition: restoring NAD+ metabolism and disease control ScienceDirect A Potent and Specific CD38 Inhibitor Ameliorates Age Related Metabolic Dysfunction by Reversing Tissue NAD+ Decline ScienceDirect
Pay in 4 interest-free payments of $6.38 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15




